Quest Diagnostics Launches Mobile Phlebotomy Service'
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics has launched a mobile phlebotomy service that allows for convenient at-home specimen collection in the United States. This service is expected to increase the accessibility of diagnostic testing for patients.
November 09, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The launch of the mobile phlebotomy service by Quest Diagnostics could potentially increase the company's customer base and revenues by making diagnostic testing more accessible.
The launch of a new service that increases accessibility to diagnostic testing could potentially attract more customers to Quest Diagnostics. This could lead to an increase in revenues and positively impact the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100